MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2

74Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

miR-221/222 are two highly homologous microRNAs that are frequently upregulated in solid tumors. However, the effects of miR-221/222 in malignant gliomas have not been investigated thoroughly. In this study, we found that miR-221/222 were significantly upregulated in human glioma samples and glioma cell lines. Both gain- and loss-of-function studies showed that miR-221/222 regulate cell proliferation, the cell cycle and apoptosis, in addition to, invasion, metastasis, and angiogenesis in glioma cell lines. Subsequent investigations revealed that TIMP2 is a direct target of miR-221/222, and overexpression of TIMP2 reduced the miR-221/222-mediated invasion, metastasis, and angiogenesis of glioma cells. Taken together, our results suggest that the suppression of miR-221/222 may be a feasible approach for inhibiting the malignant behaviors of glioma.

Cite

CITATION STYLE

APA

Yang, F., Wang, W., Zhou, C., Xi, W., Yuan, L., Chen, X., … Wang, T. (2015). MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2. Tumor Biology, 36(5), 3763–3773. https://doi.org/10.1007/s13277-014-3017-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free